382 related articles for article (PubMed ID: 23419828)
1. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD).
Izquierdo-Alonso JL; Rodriguez-Gonzálezmoro JM; de Lucas-Ramos P; Unzueta I; Ribera X; Antón E; Martín A
Respir Med; 2013 May; 107(5):724-31. PubMed ID: 23419828
[TBL] [Abstract][Full Text] [Related]
2. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
Calle Rubio M; Casamor R; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status.
Miravitlles M; Soriano JB; Ancochea J; Muñoz L; Duran-Tauleria E; Sánchez G; Sobradillo V; García-Río F
Respir Med; 2013 Jul; 107(7):1053-60. PubMed ID: 23597591
[TBL] [Abstract][Full Text] [Related]
4. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke.
Golpe R; Sanjuán López P; Cano Jiménez E; Castro Añón O; Pérez de Llano LA
Arch Bronconeumol; 2014 Aug; 50(8):318-24. PubMed ID: 24576449
[TBL] [Abstract][Full Text] [Related]
5. The use of the lower limit of normal as a criterion for COPD excludes patients with increased morbidity and high consumption of health-care resources.
Izquierdo Alonso JL; De Lucas Ramos P; Rodríguez Glez-Moro JM;
Arch Bronconeumol; 2012 Jul; 48(7):223-8. PubMed ID: 22480962
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations.
Cheng Y; Tu X; Pan L; Lu S; Xing M; Li L; Chen X
Int J Chron Obstruct Pulmon Dis; 2017; 12():2069-2074. PubMed ID: 28790809
[TBL] [Abstract][Full Text] [Related]
7. Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: "the ESPIRAL-ES study".
Alcázar-Navarrete B; Trigueros JA; Riesco JA; Campuzano A; Pérez J
Int J Chron Obstruct Pulmon Dis; 2018; 13():1115-1124. PubMed ID: 29692606
[TBL] [Abstract][Full Text] [Related]
8. Active smoking and COPD phenotype: distribution and impact on prognostic factors.
Riesco JA; Alcázar B; Trigueros JA; Campuzano A; Pérez J; Lorenzo JL
Int J Chron Obstruct Pulmon Dis; 2017; 12():1989-1999. PubMed ID: 28740378
[TBL] [Abstract][Full Text] [Related]
9. Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross-sectional multicentre study.
Corhay JL; Vincken W; Schlesser M; Bossuyt P; Imschoot J
Int J Clin Pract; 2013 Dec; 67(12):1294-301. PubMed ID: 24246208
[TBL] [Abstract][Full Text] [Related]
10. Impact of comorbidities on COPD-specific health-related quality of life.
Burgel PR; Escamilla R; Perez T; Carré P; Caillaud D; Chanez P; Pinet C; Jebrak G; Brinchault G; Court-Fortune I; Paillasseur JL; Roche N;
Respir Med; 2013 Feb; 107(2):233-41. PubMed ID: 23098687
[TBL] [Abstract][Full Text] [Related]
11. Readmission Due to Exacerbation of COPD: Associated Factors.
Cerezo Lajas A; Gutiérrez González E; Llorente Parrado C; Puente Maestu L; de Miguel-Díez J
Lung; 2018 Apr; 196(2):185-193. PubMed ID: 29445935
[TBL] [Abstract][Full Text] [Related]
12. Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery.
Miravitlles M; Soler-Cataluña JJ; Calle M; Molina J; Almagro P; Quintano JA; Riesco JA; Trigueros JA; Piñera P; Simón A; López-Campos JL; Soriano JB; Ancochea J;
Arch Bronconeumol; 2012 Jul; 48(7):247-57. PubMed ID: 22561012
[TBL] [Abstract][Full Text] [Related]
13. Clinical Features Of Women With COPD: Sex Differences In A Cross-Sectional Study In Spain ("The ESPIRAL-ES Study").
Trigueros JA; Riesco JA; Alcázar-Navarrete B; Campuzano A; Pérez J
Int J Chron Obstruct Pulmon Dis; 2019; 14():2469-2478. PubMed ID: 31806956
[TBL] [Abstract][Full Text] [Related]
14. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
Fan VS; Ramsey SD; Make BJ; Martinez FJ
COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675
[TBL] [Abstract][Full Text] [Related]
15. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease.
Shirtcliffe P; Marsh S; Travers J; Weatherall M; Beasley R
Intern Med J; 2012 Jan; 42(1):83-8. PubMed ID: 20403069
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.
Camiciottoli G; Bigazzi F; Magni C; Bonti V; Diciotti S; Bartolucci M; Mascalchi M; Pistolesi M
Int J Chron Obstruct Pulmon Dis; 2016; 11():2229-2236. PubMed ID: 27695310
[TBL] [Abstract][Full Text] [Related]
17. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].
Sleszycka J; Woźniak K; Banaszek M; Wiechno W; Domagała-Kulawik J
Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871
[TBL] [Abstract][Full Text] [Related]
19. Impairment of quality of life in women with chronic obstructive pulmonary disease.
Naberan K; Azpeitia A; Cantoni J; Miravitlles M
Respir Med; 2012 Mar; 106(3):367-73. PubMed ID: 22018505
[TBL] [Abstract][Full Text] [Related]
20. [Chronic obstructive pulmonary disorder (COPD) patients with the syndrome of combined pulmonary fibrosis and emphysema, compared to patients with emphysema alone].
Weiner P; Novitzky T; Weiner D; Beckerman M
Harefuah; 2013 May; 152(5):294-8, 308, 307. PubMed ID: 23885455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
